Proceedings of the 2024 Third Annual ASTCT-NMDP ACCESS Initiative Workshop.

IF 3.6 3区 医学 Q2 HEMATOLOGY Transplantation and Cellular Therapy Pub Date : 2024-09-13 DOI:10.1016/j.jtct.2024.09.004
Jeffery J Auletta, Jennifer Holter-Chakrabarty, Pashna Munshi, Sarah Wall, Nandita Khera, Jess Knutson, Alexandra Gomez-Arteaga, Anurekha G Hall, Jackie Foster, Amber Ruffin, Delilah Robb, Eneida Nemecek, Rayne Rouce, Stella M Davies
{"title":"Proceedings of the 2024 Third Annual ASTCT-NMDP ACCESS Initiative Workshop.","authors":"Jeffery J Auletta, Jennifer Holter-Chakrabarty, Pashna Munshi, Sarah Wall, Nandita Khera, Jess Knutson, Alexandra Gomez-Arteaga, Anurekha G Hall, Jackie Foster, Amber Ruffin, Delilah Robb, Eneida Nemecek, Rayne Rouce, Stella M Davies","doi":"10.1016/j.jtct.2024.09.004","DOIUrl":null,"url":null,"abstract":"<p><p>The Third Annual Workshop of the American Society for Transplantation and Cellular Therapy (ASTCT) and National Marrow Donor Program (NMDP) ACCESS Initiative occurred on July 23 and 24, 2024. Content from the workshop is provided to inform the hematopoietic cell transplantation (HCT) and cellular therapy (CT) ecosystem about progress and direction of the collaborative. Highlights from the meeting are reviewed, including the inaugural Corporate Roundtable and Advocacy Day, new partnerships with non-profit organizations, and updates on projects from the Awareness, Poverty and Race and Ethnicity Inequity Committees. In addition, the Junior Faculty and Trainee Immersion Program-sponsored efforts in workforce diversity and physician advocacy are presented. Lastly, continued education was provided on patient and caregiver participation as well as community engagement. As it enters its third year, the ASTCT-NMDP ACCESS Initiative will transition from foundation building as a grass roots collaborative to intentional impact in reducing barriers and improving outcome disparities for all patients in need of HCT/CT. Enthusiasm for and participation in the ACCESS Initiative remain high. Both are needed to sustain progress in achieving its goal in enabling all patients in need to receive HCT/CT.</p>","PeriodicalId":23283,"journal":{"name":"Transplantation and Cellular Therapy","volume":null,"pages":null},"PeriodicalIF":3.6000,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplantation and Cellular Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jtct.2024.09.004","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The Third Annual Workshop of the American Society for Transplantation and Cellular Therapy (ASTCT) and National Marrow Donor Program (NMDP) ACCESS Initiative occurred on July 23 and 24, 2024. Content from the workshop is provided to inform the hematopoietic cell transplantation (HCT) and cellular therapy (CT) ecosystem about progress and direction of the collaborative. Highlights from the meeting are reviewed, including the inaugural Corporate Roundtable and Advocacy Day, new partnerships with non-profit organizations, and updates on projects from the Awareness, Poverty and Race and Ethnicity Inequity Committees. In addition, the Junior Faculty and Trainee Immersion Program-sponsored efforts in workforce diversity and physician advocacy are presented. Lastly, continued education was provided on patient and caregiver participation as well as community engagement. As it enters its third year, the ASTCT-NMDP ACCESS Initiative will transition from foundation building as a grass roots collaborative to intentional impact in reducing barriers and improving outcome disparities for all patients in need of HCT/CT. Enthusiasm for and participation in the ACCESS Initiative remain high. Both are needed to sustain progress in achieving its goal in enabling all patients in need to receive HCT/CT.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2024 年第三届 ASTCT-NMDP ACCESS 计划研讨会论文集。
美国移植与细胞治疗学会(ASTCT)和美国国家骨髓捐献计划(NMDP)ACCESS 计划第三次年度研讨会于 2024 年 7 月 23 日和 24 日举行。研讨会的内容旨在向造血细胞移植 (HCT) 和细胞治疗 (CT) 生态系统通报合作的进展和方向。会议回顾了会议的亮点,包括首届企业圆桌会议和宣传日、与非营利组织的新合作关系,以及提高认识委员会、贫困委员会和种族与民族不平等委员会的最新项目情况。此外,还介绍了青年教师和实习生沉浸计划在劳动力多样性和医生宣传方面所做的努力。最后,还提供了有关患者和护理人员参与以及社区参与的继续教育。进入第三年后,ASTCT-NMDP ACCESS 计划将从基层合作的基础建设过渡到有意识地为所有需要 HCT/CT 的患者减少障碍和改善结果差异。人们对 ACCESS 计划的热情和参与度仍然很高,要想在实现让所有需要 HCT/CT 的患者都能接受 HCT/CT 的目标方面持续取得进展,就需要这两方面的努力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
7.00
自引率
15.60%
发文量
1061
审稿时长
51 days
期刊最新文献
Advanced Practice Providers in Cellular Therapy: survey results from the ASTCT APP Special Interest Group exploring clinical roles, compensation and job satisfaction. Healthcare resource utilization and associated costs in patients with chronic graft-versus-host disease post allogeneic hematopoietic stem cell transplantation in England: HCRU and associated costs in patients with cGvHD in England. Superior survival after unrelated allogeneic stem cell transplantation with low-dose ATG compared to low-dose TBI in myeloablative fludarabine/busulfan-based regimen for MDS on behalf of the adult MDS Working Group of the JSTCT. N-803, an IL-15 superagonist complex as maintenance therapy after allogeneic donor stem cell transplant for acute myeloid leukemia or myelodysplastic syndrome; a Phase 2 trial. Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1